SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST

Background: The B-FAST project of the National University Network (NUM) examines and records applied surveillance strategies implemented in hospitals i.a., to protect patients and employees from infection.Methods: Infection control physicians in German university hospitals (UK), as well as non-univ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heinemann, Stephanie, Bludau, Anna, Kaba, Hani, Knolle, Percy, Grundmann, Hajo, Scheithauer, Simone
Formato: article
Lenguaje:DE
EN
Publicado: German Medical Science GMS Publishing House 2021
Materias:
R
Acceso en línea:https://doaj.org/article/6366d2de894543d0893b1e05f52a5b0d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6366d2de894543d0893b1e05f52a5b0d
record_format dspace
spelling oai:doaj.org-article:6366d2de894543d0893b1e05f52a5b0d2021-11-25T07:15:31ZSARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST2196-522610.3205/dgkh000402https://doaj.org/article/6366d2de894543d0893b1e05f52a5b0d2021-11-01T00:00:00Zhttp://www.egms.de/static/en/journals/dgkh/2021-16/dgkh000402.shtmlhttps://doaj.org/toc/2196-5226Background: The B-FAST project of the National University Network (NUM) examines and records applied surveillance strategies implemented in hospitals i.a., to protect patients and employees from infection.Methods: Infection control physicians in German university hospitals (UK), as well as non-university hospitals (NUK; Bavaria, Lower Saxony) were surveyed in March 2021 regarding SARS-CoV-2 testing/surveillance strategies in a cross-sectional study using a standardized online questionnaire. The focus was on screening strategies taking into account the “test” methods used (case history, PCR, antigen, antibody test).Results: The response rate was 91.7% (33/36) in UK and 11.3%–32.2% in NUK. Almost all hospitals (95.0%) performed a symptom and exposure check and/or testing upon inpatient admission. Non-cause-related testing (screening) of health care workers in COVID wards was preferably done by PCR in UK (69.7% PCR; 12.1% antigen), while NUK (29.9% PCR; 49.3% antigen) used antigen testing more frequently. Regardless of the type of facility, about half of the respondents rated the benefit of screening higher than the effort (patients: 49%; employees: 45%).Conclusion: Testing/surveillance strategies find a high level of acceptance at German hospitals and are generally carried out in accordance with the national testing strategy with differences depending on the level of care.Heinemann, StephanieBludau, AnnaKaba, HaniKnolle, PercyGrundmann, HajoScheithauer, SimoneGerman Medical Science GMS Publishing Housearticlehospitalsars-cov-2screeningsurveillanceuniversity hospitalMedicineRPublic aspects of medicineRA1-1270MicrobiologyQR1-502DEENGMS Hygiene and Infection Control, Vol 16, p Doc31 (2021)
institution DOAJ
collection DOAJ
language DE
EN
topic hospital
sars-cov-2
screening
surveillance
university hospital
Medicine
R
Public aspects of medicine
RA1-1270
Microbiology
QR1-502
spellingShingle hospital
sars-cov-2
screening
surveillance
university hospital
Medicine
R
Public aspects of medicine
RA1-1270
Microbiology
QR1-502
Heinemann, Stephanie
Bludau, Anna
Kaba, Hani
Knolle, Percy
Grundmann, Hajo
Scheithauer, Simone
SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
description Background: The B-FAST project of the National University Network (NUM) examines and records applied surveillance strategies implemented in hospitals i.a., to protect patients and employees from infection.Methods: Infection control physicians in German university hospitals (UK), as well as non-university hospitals (NUK; Bavaria, Lower Saxony) were surveyed in March 2021 regarding SARS-CoV-2 testing/surveillance strategies in a cross-sectional study using a standardized online questionnaire. The focus was on screening strategies taking into account the “test” methods used (case history, PCR, antigen, antibody test).Results: The response rate was 91.7% (33/36) in UK and 11.3%–32.2% in NUK. Almost all hospitals (95.0%) performed a symptom and exposure check and/or testing upon inpatient admission. Non-cause-related testing (screening) of health care workers in COVID wards was preferably done by PCR in UK (69.7% PCR; 12.1% antigen), while NUK (29.9% PCR; 49.3% antigen) used antigen testing more frequently. Regardless of the type of facility, about half of the respondents rated the benefit of screening higher than the effort (patients: 49%; employees: 45%).Conclusion: Testing/surveillance strategies find a high level of acceptance at German hospitals and are generally carried out in accordance with the national testing strategy with differences depending on the level of care.
format article
author Heinemann, Stephanie
Bludau, Anna
Kaba, Hani
Knolle, Percy
Grundmann, Hajo
Scheithauer, Simone
author_facet Heinemann, Stephanie
Bludau, Anna
Kaba, Hani
Knolle, Percy
Grundmann, Hajo
Scheithauer, Simone
author_sort Heinemann, Stephanie
title SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
title_short SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
title_full SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
title_fullStr SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
title_full_unstemmed SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST
title_sort sars-cov-2 surveillance and testing: results of a survey from the network of university hospitals (num), b-fast
publisher German Medical Science GMS Publishing House
publishDate 2021
url https://doaj.org/article/6366d2de894543d0893b1e05f52a5b0d
work_keys_str_mv AT heinemannstephanie sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast
AT bludauanna sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast
AT kabahani sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast
AT knollepercy sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast
AT grundmannhajo sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast
AT scheithauersimone sarscov2surveillanceandtestingresultsofasurveyfromthenetworkofuniversityhospitalsnumbfast
_version_ 1718413622045048832